T-CURX raises $20M Series A for non-viral CAR-T therapies
German biotech secures funding led by BiomedVC to advance clinical programs in AML and solid tumors
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
© 1997-2026 LUMITOS AG, All rights reserved